Quest to divest HemoCue diagnostic biz for about $300 million

02/25/2013 | RTT News

Radiometer Medical has agreed to acquire Quest Diagnostics' HemoCue business for about $300 million, plus cash balance adjustments, in a deal set to be finalized next month. HemoCue focuses on developing and marketing point-of-care diagnostics, including those used in glucose and hemoglobin testing.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC